Delcath (DCTH) Q3 2026 Earnings Call Transcript
New site additions and rising treatment volume drove a strong quarter.
We haven't written up this one. Motley Fool has the full story — the link below goes straight to it.
More in Finance & Markets
How the world became too reliant on Jensen Huang
The chief executive’s travails are a reminder that a single point of failure is never a good thing for a big company
Ozempic, Zepbound and other GLP-1 drugs have a possible risk of vision loss
Several medical studies have found that people taking GLP-1 medications have an elevated risk for nonarteritic anterior ischemic optic neuropathy, or NAION.
Honeycomb Expands LRO Into Texas, Pennsylvania and New Jersey
Honeycomb Insurance announced the expansion of its Lessor’s Risk Only (LRO) coverage into Texas, Pennsylvania, and New Jersey, continuing its growth across key U.S. markets.
Luka Dončić-Led Lakers Could Be Real Western Conference Contender
A historic start for Luka Dončić has the Lakers looking like one of the West's best. Can it hold up for the whole season, though?
Rising interest rates and market trends prompt Saudis to delay property purchases
Higher interest rates, stable rents, and expectations of lower prices are leading some Saudis to postpone real estate purchases and mortgage financing.